Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-05-005176
Filing Date
2005-03-16
Accepted
2005-03-16 11:01:36
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d23209e10vk.htm 10-K 830091
2 AMENDMENT TO AMENDED/RESTATED DISTRIBUTION AND LICENSE AGREEMENT d23209exv10w26.htm EX-10.26 32433
3 LETTER AGREEMENT d23209exv10w27.htm EX-10.27 11872
4 LETTER AGREEMENT d23209exv10w28.htm EX-10.28 9215
5 LEASE d23209exv10w29.htm EX-10.29 171244
6 COUNTERPART GUARANTEE d23209exv10w30.htm EX-10.30 42887
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d23209exv23w1.htm EX-23.1 1984
8 CERTIFICATION FOR PRESIDENT AND CEO PURSUANT TO SECTION 302 d23209exv31w1.htm EX-31.1 5245
9 CERTIFICATION FOR CFO PURSUANT TO SECTION 302 d23209exv31w2.htm EX-31.2 5215
10 CERTIFICATION FOR PRESIDENT, CEO AND CFO PURSUANT TO SECTION 906 d23209exv32w1.htm EX-32.1 3587
  Complete submission text file 0000950134-05-005176.txt   1116410
Mailing Address
Business Address 2525 28TH STREET BOULDER CO 80301 720 564 9100
PHARMION CORP (Filer) CIK: 0001203866 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 000-50447 | Film No.: 05683805
SIC: 2834 Pharmaceutical Preparations